AMI-1 50 mg | 99.90%
TargetMol
AMI-1 is an effective and selective Histone Methyltransferase (HMT) inhibitor (IC50: 3.0/8.8 μM, for yeast Hmt1p, and human PRMT1).
More Information Supplier PageAMI-1
Search Results
BG45 200 mg | Purity Not Available
TargetMol
BG45 is an HDAC I type inhibitor with IC50 of 289 nM, 2.0 μM, 2.2 μM and >20 μM for HDAC3/1/2/6 in cell-free assays, respectively.
More Information Supplier PageBG45
BG45 100 mg | Purity Not Available
TargetMol
BG45 is an HDAC I type inhibitor with IC50 of 289 nM, 2.0 μM, 2.2 μM and >20 μM for HDAC3/1/2/6 in cell-free assays, respectively.
More Information Supplier PageBG45
RU 24969 hemisuccinate 100 mg | 99.92%
TargetMol
Encenicline hydrochloride 1 mg | 98.73%
TargetMol
Encenicline hydrochloride (EVP-6124 hydrochloride) is a new-type partial agonist of α7 neuronal nicotinic acetylcholine receptors (nAChRs).
More Information Supplier PageEncenicline hydrochloride
BRD7116 100 mg | 99.30%
TargetMol
BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.
More Information Supplier PageBRD7116
BX471 2 mg | 99.85%
TargetMol
BX471
Vortioxetine hydrobromide 100 mg | 99.48%
TargetMol
Vortioxetine (Lu AA21004) is a serotonin (5-HT) modulator and stimulator (SMS), inhibits 5-HT1A/1B/3A/7 receptor and SERT (IC50: 15/33/3.7/19/1.6 nM).
More Information Supplier PageVortioxetine hydrobromide
Vortioxetine hydrobromide 25 mg | 99.48%
TargetMol
Vortioxetine (Lu AA21004) is a serotonin (5-HT) modulator and stimulator (SMS), inhibits 5-HT1A/1B/3A/7 receptor and SERT (IC50: 15/33/3.7/19/1.6 nM).
More Information Supplier PageVortioxetine hydrobromide
Dapagliflozin 200 mg | 99.74%
TargetMol
Dapagliflozin is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity.
More Information Supplier PageDapagliflozin
